Literature DB >> 19961883

Converging molecular pathways in human neural development and degeneration.

Niklas Mattsson1, Karin Sävman, Gustaf Osterlundh, Kaj Blennow, Henrik Zetterberg.   

Abstract

Animal studies suggest that phosphorylation of microtubule-associated protein tau is a physiological way of destabilizing axons in the developing brain, promoting synaptic plasticity, while in the adult human brain tau phosphorylation is a specific sign of Alzheimer's disease. We here show, for the first time, that newborn human infants have extremely high levels of phosphorylated tau in their cerebrospinal fluid, and that these levels decrease during the first years of life. Tau phosphorylation in Alzheimer's disease may be a physiological response to Alzheimer-associated synaptotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19961883     DOI: 10.1016/j.neures.2009.11.012

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  16 in total

1.  A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kathleen A Delaney; Kyle Rudser; Victor Kovac; Nitin Nair; Charles W Richard; Patrick Haslett; Chester B Whitley
Journal:  J Pediatr       Date:  2016-01-16       Impact factor: 4.406

2.  Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C.

Authors:  Niklas Mattsson; Henrik Zetterberg; Simona Bianconi; Nicole M Yanjanin; Rao Fu; Jan-Eric Månsson; Forbes D Porter; Kaj Blennow
Journal:  JIMD Rep       Date:  2011-09-28

3.  Increased concentration of the CSF Tau protein and its phosphorylated form in the late juvenile metachromatic leukodystrophy form: a case report.

Authors:  Joanna Tarasiuk; Katarzyna Kapica-Topczewska; Alina Kułakowska; Dorota Halicka; Wiesław Drozdowski; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

4.  Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study.

Authors:  N Mattsson; H Zetterberg; S Bianconi; N M Yanjanin; R Fu; J-E Månsson; F D Porter; K Blennow
Journal:  Neurology       Date:  2010-12-29       Impact factor: 9.910

5.  Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years.

Authors:  Joel Simrén; Ulf Andreasson; Johan Gobom; Marc Suarez Calvet; Barbara Borroni; Christopher Gillberg; Lars Nyberg; Roberta Ghidoni; Elisabeth Fernell; Mats Johnson; Herman Depypere; Caroline Hansson; Ingibjörg H Jonsdottir; Henrik Zetterberg; Kaj Blennow
Journal:  Brain Commun       Date:  2022-07-04

6.  Enzyme replacement therapy for alpha-mannosidosis: 12 months follow-up of a single centre, randomised, multiple dose study.

Authors:  L Borgwardt; C I Dali; J Fogh; J E Månsson; K J Olsen; H C Beck; K G Nielsen; L H Nielsen; S O E Olsen; H M F Riise Stensland; O Nilssen; F Wibrand; A M Thuesen; T Pearl; U Haugsted; P Saftig; J Blanz; S A Jones; A Tylki-Szymanska; N Guffon-Fouiloux; M Beck; A M Lund
Journal:  J Inherit Metab Dis       Date:  2013-03-14       Impact factor: 4.982

Review 7.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

8.  Cerebrospinal fluid analysis should be considered in patients with cognitive problems.

Authors:  Henrik Zetterberg; Niklas Mattsson; Kaj Blennow
Journal:  Int J Alzheimers Dis       Date:  2010-07-14

9.  Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder.

Authors:  Joel Jakobsson; Henrik Zetterberg; Kaj Blennow; Carl Johan Ekman; Anette G M Johansson; Mikael Landén
Journal:  Neuropsychopharmacology       Date:  2012-11-06       Impact factor: 7.853

10.  Neurofibrillary tangle pathology and Braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study.

Authors:  Maria Thom; Joan Y W Liu; Pam Thompson; Rahul Phadke; Marta Narkiewicz; Lillian Martinian; Derek Marsdon; Matthias Koepp; Luis Caboclo; Claudia B Catarino; Sanjay M Sisodiya
Journal:  Brain       Date:  2011-09-08       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.